Catalyst Wire Dossier Catalyst Wire Dossier

IDN5243

IDN5243 · Indena S.p.A
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IDN5243, covering 2025-07-22 to 2025-07-22. Get the full timeline:

Most recent: Clinical Trial Update: Tolerability, Safety and Activity of a Muscle Relaxant Molecule IDN5243 in Patients With Low Back Pain [Phase 2]

See pricing